These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 39197425)

  • 1. Rationale and design of PURE, a randomized controlled trial to evaluate Peritoneal Ultrafiltration with PolyCore™ in Refractory Congestive Heart Failure.
    Gronda E; Gallieni M; Pacileo G; Capasso G; Wei LJ; Trepiccione F; Heidempergher M; Bonomini M; Zimarino M; Divino-Filho JC; Di Liberato L; Caracciolo MM; Masola V; Prosdocimi T; Iacobelli M; Vitagliano C; Arduini A
    Kidney Blood Press Res; 2024 Aug; ():. PubMed ID: 39197425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of peritoneal ultrafiltration in the elderly refractory congestive heart failure patients.
    Ruhi Ç; Koçak H; Yavuz A; Süleymanlar G; Ersoy FF
    Int Urol Nephrol; 2012 Jun; 44(3):963-9. PubMed ID: 22388751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The peritoneal ultrafiltration in patients with cardio-renal disease].
    Corciulo R; Corciulo S
    G Ital Nefrol; 2017 Mar; 34(Suppl 69):86-103. PubMed ID: 28682031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal ultrafiltration and refractory congestive heart failure.
    Ryckelynck JP; Lobbedez T; Valette B; Le Goff C; Mazouz O; Levaltier B; Potier JC; Hurault de Ligny B
    Adv Perit Dial; 1997; 13():93-7. PubMed ID: 9360658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal ultrafiltration in end-stage chronic heart failure.
    Fröhlich H; Katus HA; Täger T; Lossnitzer N; Grossekettler L; Kihm L; Zeier M; Remppis A; Frankenstein L; Schwenger V
    Clin Kidney J; 2015 Apr; 8(2):219-25. PubMed ID: 25815181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal ultrafiltration in end-stage congestive heart failure.
    Wojtaszek E; Małyszko J; Matuszkiewicz-Rowińska J
    Cardiol J; 2014; 21(2):115-20. PubMed ID: 24526501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialysis initiation and survival in patients with refractory congestive heart failure.
    Fabbian F; Cantelli S; Molino C; Pala M; Longhini C
    Int J Artif Organs; 2009 Aug; 32(8):492-5. PubMed ID: 19844893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal ultrafiltration in older adult patients with advanced heart failure.
    Rodríguez-Álvarez A; Piñeiro-Fernández JC; Guerrero-Sande H; Chaos-González MP; Pérez-López A; González-Tabara L; Millan-Díaz B; Cerqueiro-González JM
    Intern Emerg Med; 2023 Sep; 18(6):1665-1671. PubMed ID: 37261558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and Safety of Peritoneal Dialysis Treatment in Patients with Refractory Congestive Heart Failure due to Chronic Cardiorenal Syndrome.
    Shao Q; Xia Y; Zhao M; Liu J; Zhang Q; Jin B; Xie J; Xu B; Gong R; Jiang C
    Biomed Res Int; 2018; 2018():6529283. PubMed ID: 29888270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal ultrafiltration in refractory heart failure: a cohort study.
    Bertoli SV; Musetti C; Ciurlino D; Basile C; Galli E; Gambaro G; Iadarola G; Guastoni C; Carlini A; Fasciolo F; Borzumati M; Gallieni M; Stefania F
    Perit Dial Int; 2014; 34(1):64-70. PubMed ID: 24179103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal versus peritoneal ultrafiltration in diuretic-resistant congestive heart failure--a review.
    Wańkowicz Z; Próchnicka A; Olszowska A; Baczyński D; Krzesiński P; Dziuk M
    Med Sci Monit; 2011 Dec; 17(12):RA271-81. PubMed ID: 22129914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
    Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
    Trials; 2021 May; 22(1):342. PubMed ID: 34001174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal dialysis in patients with refractory congestive heart failure: a systematic review.
    Lu R; Muciño-Bermejo MJ; Ribeiro LC; Tonini E; Estremadoyro C; Samoni S; Sharma A; Zaragoza Galván Jde J; Crepaldi C; Brendolan A; Ni Z; Rosner MH; Ronco C
    Cardiorenal Med; 2015 Apr; 5(2):145-56. PubMed ID: 25999963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tidal peritoneal dialysis versus ultrafiltration in type 1 cardiorenal syndrome: A prospective randomized study.
    Al-Hwiesh AK; Abdul-Rahman IS; Al-Audah N; Al-Hwiesh A; Al-Harbi M; Taha A; Al-Shahri A; Ghazal S; Amir R; Al-Audah N; Mansour H; El-Mansouri M; El-Salamony TS; Nasr El-Din MA; Noor A; Al-Elq Z; Alzahir ZH; Alzawad NA
    Int J Artif Organs; 2019 Dec; 42(12):684-694. PubMed ID: 31303099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.